Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

Oncobiologics, Inc.

TRADE

NASDAQ: ONSIZHealthcare / Biotechnology / USA
0.020-23.81%Vol 80 9001Y Perf -95.00%
May 16th, 2018 19:19
BID0.00 ASK0.00
Open0.03 Previous Close0.02
Pre-Market- After-Trading-
 - -%  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potencial %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
 —    -
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)- 
Earnings Rating
Price Range Ratio 52wk %
0.00 
Earnings Date

Today's Price Range

0.010.03

 

52wk Range

0.010.32

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
0.00%
3 Months
0.00%
6 Months
-60.00%
1 Year
-95.00%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ONSIZ0.020.0000-23.81
AAPL221.19-0.9600-0.43
GOOG1 115.69-5.5900-0.50
MSFT110.71-0.2900-0.26
XOM81.500.30000.37
WFC54.460.73001.36
JNJ139.462.90002.12
FB159.420.64000.40
GE12.190.09000.74
JPM109.831.21001.11
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio -
Current Ratio -
Long Term Debt to Total Capital -
Total Debt to Equity -
Interest Coverage -
Leverage Ratio -
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-
EBITDA Margin-
Pre-tax Profit Margin-
Profit Margin-
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio -
PS Ratios -
Price to Cash Flow -
Price to Free Cash Flow -
Cash Flow Per Share -
Price to Tangible Book-
Book Value per Share-
Enterprise Value (in ths.)-
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -
Return on Assets (5Y Avg) -
ROA last 12 Months -
Return on Capital (5Y Avg) -
ROC last 12 Months -
Return on invested Capital Q -
Return on invested Capital Y-
Assets Turnover-
Receivables Turnover-
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)-
Revenue per Share -
Revenue Growth 3 Years -
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
----
----
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume80 900
Shares Outstanding (in ths.)0
Trades Count34
Dollar Volume1 688
Avg. Volume19 510
Avg. Weekly Volume86 700
Avg. Monthly Volume25 395
Avg. Quarterly Volume22 590

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

0%100%

Bearish Bullish

56%44%

Bearish Bullish

64%36%

Bearish Bullish

66%34%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Rating---

There are no comments yet.

News

x